Acalabrutinib 100 mg is a Bruton tyrosine kinase (BTK) inhibitor used to treat certain blood cancers, including chronic lymphocytic leukaemia (CLL) and small lymphocytic lymphoma (SLL).
|
|||||||||||||||||||||
Acalabrutinib 100 mg Australia
Price range: $240.00 through $583.20
Reviews (0)
There are no reviews yet.